UOCT Performance — Innovator U.S. Equity Ultra Buffer ETF - October
Data updated: 2026-10-01
UOCT returned +6.17% year to date and +10.82% over one year to Jul 2026. Annualised returns are +11.18% over 3 years and +8.33% over 5 years. The fund beat its Trading - Leveraged category average: $100 invested three years ago grew to $137, against $136 for the category, and to $111 over one year, against $105. Volatility over the past three years was 5.82% a year. In the 12 months to Jul 2026 the fund took in a net $7.0M, and assets reached $179.24M.
UOCT Growth of $100
What $100 invested in Innovator U.S. Equity Ultra Buffer ETF - October grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | UOCT | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $111 | $105 |
| 3 years (Aug 2023 – Jul 2026) | $137 | $136 |
| 5 years (Aug 2021 – Jul 2026) | $149 | $130 |
| Since data start (Feb 2020 – Jul 2026) | $166 | $143 |
UOCT Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.17% |
| 1 year | +10.82% |
| 3 years (annualised) | +11.18% |
| 5 years (annualised) | +8.33% |
UOCT Annual Returns
Calendar-year total returns of Innovator U.S. Equity Ultra Buffer ETF - October, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +6.17% |
| 2025 | +10.49% |
| 2024 | +9.12% |
| 2023 | +19.06% |
| 2022 | −4.38% |
| 2021 | +5.84% |
| 2020 (Feb–Dec) | +7.55% |
UOCT Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.8% | −0.2% | −2.4% | +5.1% | +2.0% | +0.2% | +0.7% | — | — | — | — | — |
| 2025 | +1.5% | −0.5% | −3.2% | +0.1% | +3.3% | +3.1% | +1.6% | +1.4% | +1.2% | +0.9% | +0.4% | +0.4% |
| 2024 | +1.0% | +1.6% | +1.0% | −0.4% | +1.7% | +0.7% | +0.5% | +0.7% | +0.4% | −0.5% | +2.8% | −0.9% |
| 2023 | +4.0% | −1.0% | +2.0% | +1.4% | +0.9% | +2.3% | +0.9% | +0.5% | +0.5% | −1.1% | +5.1% | +2.2% |
| 2022 | −0.8% | −1.0% | +1.0% | −3.1% | +0.2% | −3.5% | +2.6% | −2.5% | −0.9% | +2.8% | +2.6% | −1.7% |
| 2021 | −0.7% | +0.8% | +1.5% | +0.8% | +0.4% | +0.4% | +0.1% | +0.2% | 0.0% | +1.4% | −0.7% | +1.5% |
| 2020 | — | −2.4% | −5.2% | +5.0% | +2.2% | +0.5% | +2.0% | +1.6% | +0.5% | −1.0% | +4.0% | +0.6% |
UOCT Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 5.82%
- 3-year Sharpe ratio: 1.15 (vs 4.5% risk-free rate)
- Best month: +5.10% (Apr 2026)
- Worst month: −3.23% (Mar 2025)
UOCT Fund Flows
Monthly money in and out of Innovator U.S. Equity Ultra Buffer ETF - October, from SEC Form N-PORT.
- 12-month net flow: $7.0M
- 12-month gross sales (incl. reinvestments): $104.8M
- Sales ÷ redemptions: 1.07×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $0 | $0 | $0 |
| Jun 2026 | $0 | $6.1M | −$6.1M |
| May 2026 | $0 | $0 | $0 |
| Apr 2026 | $0 | $64.0M | −$64.0M |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $0 | $0 | $0 |
| Jan 2026 | $0 | $984K | −$984K |
| Dec 2025 | $965K | $2.9M | −$1.9M |
| Nov 2025 | $60.6M | $3.9M | $56.7M |
| Oct 2025 | $41.3M | $959K | $40.4M |
| Sep 2025 | $1.9M | $4.8M | −$2.9M |
| Aug 2025 | $0 | $14.2M | −$14.2M |
UOCT Assets Under Management
Net assets of Innovator U.S. Equity Ultra Buffer ETF - October by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $179.24M |
| 2026-04-30 | $180.14M |
| 2026-01-31 | $238.96M |
| 2025-10-31 | $181.01M |
| 2025-07-31 | $152.40M |
| 2025-04-30 | $206.45M |
| 2025-01-31 | $201.65M |
| 2024-10-31 | $158.59M |
| 2024-07-31 | $94.75M |
| 2024-04-30 | $93.69M |
| 2024-01-31 | $93.22M |
| 2023-10-31 | $102.54M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.